查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2017520

视讯喉镜市场：按便携性、一次性类型、最终用户和应用划分－2026-2032年全球市场预测

Video Laryngoscope Market by Portability, Disposable Status, End User, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，视讯喉镜市场价值将达到 7.2334 亿美元，到 2026 年将成长至 7.8578 亿美元，到 2032 年将达到 13.4212 亿美元，年复合成长率为 9.23%。

主要市场统计数据
基准年 2025 7.2334亿美元
预计年份：2026年 7.8578亿美元
预测年份 2032 1,342,120,000 美元
复合年增长率 (%) 9.23%

诊断影像、感染控制和临床工作流程的最新进展，过程视讯喉镜成为各种呼吸道管理场景中不可或缺的工具。

呼吸道管理的进步已使可视喉镜从专用辅助设备转变为现代临床实践的核心组成部分。影像、人体工学和感染控制的改进促使临床医生和采购经理重新评估传统的插管和气道可视化方法。因此，医疗机构现在优先采用那些能够提高首次插管成功率、减少手术相关併发症并能无缝整合到多学科工作流程中的设备。

技术、临床和营运趋势的融合正在重塑气道视觉化设备的设计、采购重点和部署途径。

随着技术、临床和操作方面的变革不断融合，视讯喉镜领域正在经历一场变革，重新定义了人们对气道设备的期望。在技​​术层面，高解析度感测器、改进的光学系统和整合式录影功能提高了诊断清晰度，并简化了培训和品质保证流程。除了这些硬体改进之外，具备增强影像稳定性和医院网路相容性的智慧软体也正在涌现，以支援记录管理和远端会诊。

2025 年关税主导的贸易调整如何促使各产业重组供应链、重新思考采购方式并适应策略采购。

美国2025年实施的关税和贸易政策调整，给整个视讯喉镜生态系统带来了巨大的成本负担，并迫使其进行策略调整。依赖跨境供应链的製造商和经销商被迫重新评估零件采购，分摊增加的接收成本，并检验其产品线的价格弹性。为此，多家公司开始重组其供应商网络，并实施紧急应变计划，以确保及时向临床客户交付产品。

可操作的細項分析揭示最终用户环境、临床应用、一次性用品选择、价格范围、便携性和销售管道如何影响采购选择。

以最终用户、应用、一次性使用、价格、便携性和销售管道对市场进行细分，可以揭示影响产品设计和商业性策略的微妙需求驱动因素和采购考虑。考虑在门诊手术中心和医院采购的机构需要根据这些环境在处理能力、消毒能力和临床严重程度方面的差异进行调整。在医院内部，公立和私立机构之间的差异显着，而私立医院又可以进一步细分为需要广泛设备功能的综合医院和通常优先考虑特定医疗领域功能的专科医院。

区域市场准入考量和临床重点需要针对特定区域的产品策略、灵活的支援系统和高度适应性的采购模式。

区域趋势反映了独特的临床重点、法规环境和采购行为，这些因素影响着整个医疗保健系统对视讯喉镜解决方案的采用和支持。在美洲，需求模式体现了先进的三级医疗中心和社区医院的混合需求，这些机构优先考虑设备的互通性、培训计划和感染控制能力。该地区的采购週期通常涉及正式的价值分析和基于委员会的采购流程，其驱动因素是对临床证据和上市后支持的预期。

竞争格局、伙伴关係和服务模式如何影响医疗机构的产品蓝图、临床部署和供应商选择标准？

视讯喉镜市场的公司层面发展趋势呈现出多元化的特点：既有老牌医疗设备製造商不断拓展其呼吸道管理产品系列，也有专注于提供利基创新产品的专业製造商，还有专注于携带式、一次性或软体赋能设备的新兴挑战者。老牌製造商继续利用其品牌知名度、全球服务网络和与医院的良好合作关係，而新兴挑战者则优先考虑设计灵活性、成本效益和精准的临床定位。

在产品开发、供应链韧性和买家参与方面采取优先策略行动，以增强临床导入和采购成果。

产业领导者若想巩固市场地位并更好地服务临床客户，应优先考虑协作式方法，将产品设计、供应链韧性和客户支援有机结合。首先，应投资于模组化产品架构，使医疗机构能够根据自身门诊中心、综合医院或专科医疗机构的实际情况选择最合适的配置，从而提高产品适用性并减少采购摩擦。同样重要的是，应拓展携带式和耐用型产品的范围，以满足急诊医学和床边重症监护的需求，同时确保影像品质。

透过与临床医生的访谈、采购咨询以及交叉检验的公开数据，采用混合方法研究，获得了实用且检验的见解。

本执行摘要的研究采用了一种混合方法，结合了定性研究、二手资讯整合和检验，以确保得出可靠的结论。主要资讯来源包括对麻醉科、急诊科和重症监护科临床医生的结构化访谈，以及与医院采购负责人和分销商的讨论，旨在揭示营运和采购实践中的细微差别。这些讨论有助于我们从背景层面理解不同医疗机构对设备性能、消毒能力和培训要求的期望。

整合临床、营运和策略见解，以确定当前的部署环境并突显永续部署成功的优先事项。

总而言之，随着技术进步、感染控制重点和采购现实的共同作用，视讯喉镜的市场格局正在迅速变化，临床应用和商业策略也随之重塑。兼具临床可靠性、易操作性和完善售后支援的设备最能满足从门诊到高级医院科室等各种医疗机构的需求。价值链上的各相关人员越来越重视基于生命週期成本、供应链韧性和可验证的临床结果来评估采购决策。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 视讯 Radion Goscope 市场 便携式

  • 不可携带式
  • 携带式的

第九章：视讯喉镜市场－一次性使用或非一次性使用

  • 可重复使用的
  • 一次性的

第十章：视讯放射眼镜市场：依最终用户划分

  • 门诊手术中心
  • 医院
    • 私立医院
      • 综合医院
      • 专科医院
    • 公立医院

第十一章：视讯喉镜市场：按应用领域划分

  • 麻醉
  • 重症监护
  • 紧急医疗护理

第十二章：视讯内衣市场：按地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章：视讯放射眼镜市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章：视讯舌镜市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国视讯舌镜市场

第十六章：中国视讯广播妖精市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Ambu A/S
  • B. Braun Melsungen AG
  • Clarus Medical LLC
  • Dragerwerk AG & Co. KGaA
  • HOYA Corporation
  • ICU Medical, Inc.
  • Karl Storz SE & Co. KG
  • Medtronic plc
  • Olympus Corporation
  • Teleflex Incorporated
  • Verathon Inc.
Product Code: MRR-0376B2CAAFEF

The Video Laryngoscope Market was valued at USD 723.34 million in 2025 and is projected to grow to USD 785.78 million in 2026, with a CAGR of 9.23%, reaching USD 1,342.12 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 723.34 million
Estimated Year [2026] USD 785.78 million
Forecast Year [2032] USD 1,342.12 million
CAGR (%) 9.23%

How contemporary advances in imaging, infection control, and clinical workflows have recast video laryngoscopes as essential tools across diverse airway management settings

The evolution of airway management has propelled video laryngoscopy from a specialized adjunct to a central component of contemporary clinical practice. Advances in imaging, ergonomics, and infection control have led clinicians and procurement leaders to re-evaluate conventional approaches to intubation and airway visualization. Consequently, healthcare facilities now prioritize tools that improve first-pass success, reduce procedure-related complications, and integrate seamlessly into multidisciplinary workflows.

As clinicians confront increasingly complex patient populations, the role of video laryngoscopes has expanded across perioperative care, emergency response, and intensive care settings. Hospitals and ambulatory centers are balancing clinical efficacy with operational considerations such as device turnover, sterilization logistics, and staff training. Meanwhile, manufacturers are responding with product portfolios that range from compact, portable systems to feature-rich, premium consoles, enabling purchasers to match technology to clinical context and budgetary constraints.

Importantly, adoption decisions are influenced by a broader ecosystem that includes infection-prevention imperatives, training requirements for new devices, and the desire for interoperability with existing audiovisual and electronic medical records infrastructure. These forces are reshaping procurement criteria away from single-item purchases toward lifecycle-oriented decisions that account for consumables, service agreements, and long-term clinical value. This introductory overview sets the stage for deeper analysis of drivers, headwinds, and strategic implications in the subsequent sections.

The combined technological, clinical, and operational trends that are reshaping device design, procurement priorities, and adoption pathways in airway visualization

The landscape of video laryngoscopy is being transformed by converging technological, clinical, and operational shifts that are redefining expectations for airway devices. On the technological front, higher-resolution sensors, improved optics, and integrated recording capabilities have elevated diagnostic clarity and facilitated training and quality assurance. These hardware improvements are accompanied by smarter software, including enhanced image stabilization and compatibility with hospital networks, which support documentation and remote consultation.

Clinically, the standard of care is moving toward devices that enhance first-attempt intubation success while minimizing trauma and aerosol generation in infectious contexts. This clinical emphasis is prompting broader adoption across anesthesia, emergency medicine, and critical care, expanding the procedural envelope beyond operating rooms into prehospital and bedside environments. Consequently, device design is prioritizing factors such as portability, ease of sterilization, and single-use options to address infection prevention and turnover needs.

Operationally, procurement is influenced by total-cost-of-ownership thinking. Hospital leaders and ambulatory center administrators are increasingly weighing service contracts, disposable consumable profiles, and staff training investments when selecting solutions. Supply chain resilience has also surfaced as a strategic priority; manufacturers and buyers are exploring diversified sourcing, regional assembly, and inventory model adjustments to mitigate disruptions. Taken together, these transformative shifts are driving an environment where clinical performance, logistical simplicity, and procurement flexibility determine competitive advantage.

How 2025 tariff-driven trade adjustments prompted supply chain restructuring, procurement re-evaluation, and strategic sourcing adaptations across the industry

Policy changes to tariffs and trade measures implemented by the United States in 2025 have introduced a material layer of cost and strategic recalibration across the video laryngoscope ecosystem. Manufacturers and distributors that rely on cross-border supply chains have had to re-assess component sourcing, allocate increased landed costs, and examine the price elasticity of their product lines. In response, several firms commenced reconfiguring supplier networks and advancing contingency plans to preserve delivery timelines and product availability for clinical customers.

As an immediate consequence, procurement teams began scrutinizing unit economics and consumable dependence with greater intensity. Hospitals and surgical centers are weighing the trade-offs between reusable systems that require sterilization infrastructure and single-use alternatives that shift costs to disposables. Over time, procurement strategies have tilted toward assurances of supply continuity and predictable replenishment, with some buyers favoring vendors able to demonstrate regional sourcing or domestic assembly capabilities.

Meanwhile, manufacturers accelerated product differentiation efforts to protect margin structures while remaining competitive. Companies explored cost engineering opportunities, localized components procurement, and selective onshoring for critical subassemblies to reduce exposure to tariff-driven price pressures. Strategic partnerships with regional distributors and contract manufacturers emerged as practical measures to maintain market access and service coverage.

Finally, regulatory compliance and customs classification became operational priorities, as misclassification risks and administrative delays can translate into extended lead times for clinical customers. In sum, the cumulative impact of tariff changes has been to intensify supply chain visibility, shift procurement criteria toward resilience and predictability, and prompt industry players to pursue structural adjustments that align cost recovery with clinical value.

Practical segmentation analysis revealing how end user environments, clinical applications, disposable options, pricing tiers, portability, and sales channels shape procurement choices

Disaggregating the landscape by end user, application, disposable status, price, portability, and sales channel reveals nuanced demand drivers and procurement considerations that influence product design and commercial approaches. Organizations evaluating purchases across ambulatory surgery centers and hospitals must reconcile the differing throughput, sterilization capacity, and clinical acuity found in these settings; within hospitals the contrast between public and private institutions matters, and private hospitals further separate into multi-specialty hospitals that need broad device versatility and specialty hospitals that often prioritize discipline-specific features.

Application-specific dynamics are also central to device selection. Clinical teams in anesthesia value consistent performance across elective and complex procedures, whereas critical care clinicians require devices that function reliably at the bedside for prolonged use and under variable lighting. Emergency medicine practitioners demand rapid-deployment systems that perform in unpredictable environments. These application imperatives drive product differentiation, training needs, and accessory inventories.

Disposable status is a decisive operational consideration. Reusable systems can offer lower per-procedure hardware expenditure but require validated reprocessing cycles, quality assurance, and downtime planning. Single-use devices eliminate reprocessing burdens and reduce infection transmission concerns, yet they shift recurring costs into consumables purchasing and inventory management.

Price segmentation manifests across economy, midrange, and premium tiers, each catering to different procurement rationales. Economy devices are often selected by resource-constrained facilities seeking essential functionality, midrange systems balance cost with enhanced ergonomics and imaging, and premium offerings emphasize advanced imaging, recording, and integration capabilities for high-acuity environments. Portability further modifies acquisition logic: non-portable systems emphasize console performance and multi-user infrastructure, while portable devices are designed for point-of-care accessibility and rapid redeployment.

Finally, sales channel strategies influence how products reach end users and how support is delivered. Distributor sales enable broader geographic reach and localized support networks; hospital direct channels offer stronger contractual alignment for enterprise deployments and service-level agreements; online sales provide convenience and rapid procurement for lower-cost or replacement items. Together, these segmentation lenses inform product roadmaps, after-sales support models, and clinical training investments.

Regional go-to-market considerations and clinical priorities that require localized product strategies, flexible support networks, and adaptive procurement models

Regional dynamics present distinct clinical priorities, regulatory environments, and procurement behaviors that influence how video laryngoscopy solutions are adopted and supported across health systems. In the Americas, demand patterns reflect a mix of advanced tertiary care centers and community hospitals that prioritize device interoperability, training programs, and infection prevention capabilities. Procurement cycles here often include formal value analyses and committee-based purchasing processes, creating expectations for clinical evidence and post-sale support.

Across Europe, the Middle East & Africa, regulatory diversity and variable health infrastructure create a mosaic of buyer needs. High-income European health systems emphasize rigorous clinical validation, interoperability with hospital information systems, and environmental sustainability considerations. Meanwhile, markets within the Middle East & Africa region may prioritize devices that balance robust performance with logistical simplicity and serviceability in distributed care settings. These regional contrasts invite vendors to offer modular product suites and flexible service models.

In the Asia-Pacific region, rapid expansion of procedural capacity, investment in tertiary care facilities, and a growing base of training programs are driving adoption of both portable and integrated systems. Procurement authorities in this region often weigh lifecycle costs, local regulatory certification timelines, and the availability of consumables when evaluating suppliers. Across these regional contexts, successful commercial strategies combine clinical partnership, local service infrastructure, and tailored financing or leasing options that align with institutional purchasing norms.

Taken together, geographic insights underscore the importance of regionalized go-to-market playbooks, investment in local technical support networks, and adaptive pricing structures that reflect differing procurement frameworks and clinical priorities.

How competitive dynamics, partnerships, and service models are shaping product roadmaps, clinical adoption, and vendor selection criteria across healthcare institutions

Company-level dynamics in the video laryngoscope space are characterized by a mixture of established medical device firms expanding airway portfolios, specialized manufacturers delivering niche innovation, and emerging challengers focused on portable, single-use, or software-enabled devices. Legacy device makers continue to leverage brand recognition, global service networks, and established hospital relationships, while challenger firms emphasize design agility, cost-effective manufacturing, and targeted clinical positioning.

Collaborations between manufacturers and hospital systems have become more common, enabling iterative product refinement driven by frontline clinician feedback. Partnerships with contract manufacturers and regional distributors support scalability and after-sales coverage, particularly in markets where localized support is a procurement prerequisite. Additionally, strategic M&A activity and licensing agreements have been used to acquire complementary technologies, extend product lines into adjacent clinical segments, and accelerate access to digital capabilities such as recording and analytics.

Service models are differentiating competitive advantage: companies that offer robust clinical training, responsive technical support, and transparent consumable pricing report higher engagement with institutional procurement committees. Product roadmaps increasingly prioritize integration capabilities, including image capture for training purposes, compatibility with endoscopy towers, and potential connectivity to hospital documentation systems. These capabilities are influencing procurement dialogues and shaping vendor selection criteria across institutions.

Prioritized strategic actions for product development, supply chain resilience, and buyer engagement to strengthen clinical adoption and procurement outcomes

Industry leaders seeking to strengthen market position and better serve clinical customers should prioritize a coordinated approach that aligns product design, supply chain resilience, and buyer support. First, invest in modular product architectures that allow facilities to choose configurations suited to ambulatory centers, multi-specialty hospitals, or specialty institutions, thereby improving fit for purpose and reducing procurement friction. Equally important is the expansion of portable and durable options that serve emergency medicine and bedside critical care without compromising image quality.

Second, enhance supply chain transparency and regional sourcing capabilities to mitigate tariff exposure and delivery risk. Establishing relationships with regional contract manufacturers and maintaining strategic component inventories will reduce lead-time variability and reassure procurement teams about continuity. Third, develop flexible commercial models that include service-level agreements, consumable bundling, leasing options, and training packages to address diverse procurement behaviors across public and private institutions.

Fourth, invest in clinician-centered training programs and digital tools that support competency development and quality assurance. Simultaneously, prioritize simplified reprocessing workflows for reusable systems and clear lifecycle cost communication to enable evidence-based purchasing decisions. Finally, adopt a data-driven approach to product development by integrating clinician feedback loops, post-market performance monitoring, and iterative enhancements that reflect real-world use cases. These steps will strengthen clinical trust and differentiate offerings in a competitive environment.

Mixed-methods research grounded in clinician interviews, procurement consultations, and cross-validated public documentation to ensure practical and verifiable insights

The research underpinning this executive summary employed a mixed-methods approach that combined primary qualitative engagement with secondary intelligence synthesis and triangulation to ensure robust insights. Primary inputs included structured interviews with clinicians across anesthesia, emergency medicine, and critical care, along with consultations with hospital procurement leaders and distributor representatives to surface operational and purchasing nuances. These discussions provided contextual understanding of device performance expectations, sterilization capacity, and training requirements across different care settings.

Secondary analysis incorporated a review of publicly available regulatory guidance, device clearance announcements, clinical best-practice literature, and supplier technical specifications to validate emergent themes. Wherever possible, cross-referencing between primary testimony and secondary documentation was used to reconcile differing perspectives and to identify consistent operational pain points. Key methodological safeguards included verification of device feature claims against manufacturer technical files and alignment of procurement process descriptions with institutional purchasing policies.

Limitations of the methodology are acknowledged: qualitative insights reflect stakeholder perspectives and operational experiences rather than extrapolated numerical estimates. Additionally, the diversity of healthcare settings means that localized procurement practices may vary from the general patterns described here. To mitigate these constraints, the research emphasized thematic consistency across multiple geographies and disciplines and prioritized insights that demonstrate replicability in clinical practice and procurement decision-making. This methodological approach ensures that the conclusions and recommendations are grounded in practitioner experience and documented product attributes.

Synthesis of clinical, operational, and strategic insights that define the current adoption environment and highlight priorities for sustained implementation success

In summary, the video laryngoscope landscape is evolving rapidly as technological improvements, infection-prevention priorities, and procurement realism converge to reshape clinical adoption and commercial strategy. Devices that combine clinical reliability with operational simplicity and strong post-sale support are best positioned to meet the needs of diverse care settings ranging from ambulatory centers to high-acuity hospital departments. Stakeholders across the value chain are increasingly evaluating purchases through the lens of lifecycle cost, supply chain resilience, and demonstrable clinician outcomes.

Tariff-driven trade changes and geopolitical dynamics have highlighted the importance of supply chain transparency and regional operational strategies, prompting manufacturers and buyers alike to seek arrangements that prioritize continuity and predictable access. Product segmentation across disposable status, price tiers, portability, and sales channels continues to influence both product development and procurement behavior, emphasizing the need for adaptable offerings that can be tailored to institutional priorities.

Ultimately, organizations that align clinical evidence, flexible commercial models, and robust service delivery will gain competitive advantage. The recommendations presented herein offer actionable pathways for companies and health systems to navigate current disruptions while positioning for sustainable adoption of video laryngoscopy as a core clinical tool.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Video Laryngoscope Market, by Portability

  • 8.1. Non Portable
  • 8.2. Portable

9. Video Laryngoscope Market, by Disposable Status

  • 9.1. Reusable
  • 9.2. Single Use

10. Video Laryngoscope Market, by End User

  • 10.1. Ambulatory Surgery Centers
  • 10.2. Hospitals
    • 10.2.1. Private Hospitals
      • 10.2.1.1. Multi-Specialty Hospitals
      • 10.2.1.2. Specialty Hospitals
    • 10.2.2. Public Hospitals

11. Video Laryngoscope Market, by Application

  • 11.1. Anesthesia
  • 11.2. Critical Care
  • 11.3. Emergency Medicine

12. Video Laryngoscope Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Video Laryngoscope Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Video Laryngoscope Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Video Laryngoscope Market

16. China Video Laryngoscope Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Ambu A/S
  • 17.6. B. Braun Melsungen AG
  • 17.7. Clarus Medical LLC
  • 17.8. Dragerwerk AG & Co. KGaA
  • 17.9. HOYA Corporation
  • 17.10. ICU Medical, Inc.
  • 17.11. Karl Storz SE & Co. KG
  • 17.12. Medtronic plc
  • 17.13. Olympus Corporation
  • 17.14. Teleflex Incorporated
  • 17.15. Verathon Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL VIDEO LARYNGOSCOPE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL VIDEO LARYNGOSCOPE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL VIDEO LARYNGOSCOPE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL VIDEO LARYNGOSCOPE MARKET SIZE, BY PORTABILITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL VIDEO LARYNGOSCOPE MARKET SIZE, BY DISPOSABLE STATUS, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL VIDEO LARYNGOSCOPE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL VIDEO LARYNGOSCOPE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL VIDEO LARYNGOSCOPE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL VIDEO LARYNGOSCOPE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL VIDEO LARYNGOSCOPE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES VIDEO LARYNGOSCOPE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA VIDEO LARYNGOSCOPE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL VIDEO LARYNGOSCOPE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL VIDEO LARYNGOSCOPE MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL VIDEO LARYNGOSCOPE MARKET SIZE, BY NON PORTABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL VIDEO LARYNGOSCOPE MARKET SIZE, BY NON PORTABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL VIDEO LARYNGOSCOPE MARKET SIZE, BY NON PORTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL VIDEO LARYNGOSCOPE MARKET SIZE, BY PORTABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL VIDEO LARYNGOSCOPE MARKET SIZE, BY PORTABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL VIDEO LARYNGOSCOPE MARKET SIZE, BY PORTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL VIDEO LARYNGOSCOPE MARKET SIZE, BY DISPOSABLE STATUS, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL VIDEO LARYNGOSCOPE MARKET SIZE, BY REUSABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL VIDEO LARYNGOSCOPE MARKET SIZE, BY REUSABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL VIDEO LARYNGOSCOPE MARKET SIZE, BY REUSABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL VIDEO LARYNGOSCOPE MARKET SIZE, BY SINGLE USE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL VIDEO LARYNGOSCOPE MARKET SIZE, BY SINGLE USE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL VIDEO LARYNGOSCOPE MARKET SIZE, BY SINGLE USE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL VIDEO LARYNGOSCOPE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL VIDEO LARYNGOSCOPE MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL VIDEO LARYNGOSCOPE MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL VIDEO LARYNGOSCOPE MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL VIDEO LARYNGOSCOPE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL VIDEO LARYNGOSCOPE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL VIDEO LARYNGOSCOPE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL VIDEO LARYNGOSCOPE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL VIDEO LARYNGOSCOPE MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL VIDEO LARYNGOSCOPE MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL VIDEO LARYNGOSCOPE MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL VIDEO LARYNGOSCOPE MARKET SIZE, BY PRIVATE HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL VIDEO LARYNGOSCOPE MARKET SIZE, BY MULTI-SPECIALTY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL VIDEO LARYNGOSCOPE MARKET SIZE, BY MULTI-SPECIALTY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL VIDEO LARYNGOSCOPE MARKET SIZE, BY MULTI-SPECIALTY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL VIDEO LARYNGOSCOPE MARKET SIZE, BY SPECIALTY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL VIDEO LARYNGOSCOPE MARKET SIZE, BY SPECIALTY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL VIDEO LARYNGOSCOPE MARKET SIZE, BY SPECIALTY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL VIDEO LARYNGOSCOPE MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL VIDEO LARYNGOSCOPE MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL VIDEO LARYNGOSCOPE MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL VIDEO LARYNGOSCOPE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL VIDEO LARYNGOSCOPE MARKET SIZE, BY ANESTHESIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL VIDEO LARYNGOSCOPE MARKET SIZE, BY ANESTHESIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL VIDEO LARYNGOSCOPE MARKET SIZE, BY ANESTHESIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL VIDEO LARYNGOSCOPE MARKET SIZE, BY CRITICAL CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL VIDEO LARYNGOSCOPE MARKET SIZE, BY CRITICAL CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL VIDEO LARYNGOSCOPE MARKET SIZE, BY CRITICAL CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL VIDEO LARYNGOSCOPE MARKET SIZE, BY EMERGENCY MEDICINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL VIDEO LARYNGOSCOPE MARKET SIZE, BY EMERGENCY MEDICINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL VIDEO LARYNGOSCOPE MARKET SIZE, BY EMERGENCY MEDICINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL VIDEO LARYNGOSCOPE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. AMERICAS VIDEO LARYNGOSCOPE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 49. AMERICAS VIDEO LARYNGOSCOPE MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 50. AMERICAS VIDEO LARYNGOSCOPE MARKET SIZE, BY DISPOSABLE STATUS, 2018-2032 (USD MILLION)
  • TABLE 51. AMERICAS VIDEO LARYNGOSCOPE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 52. AMERICAS VIDEO LARYNGOSCOPE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 53. AMERICAS VIDEO LARYNGOSCOPE MARKET SIZE, BY PRIVATE HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 54. AMERICAS VIDEO LARYNGOSCOPE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 55. NORTH AMERICA VIDEO LARYNGOSCOPE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. NORTH AMERICA VIDEO LARYNGOSCOPE MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 57. NORTH AMERICA VIDEO LARYNGOSCOPE MARKET SIZE, BY DISPOSABLE STATUS, 2018-2032 (USD MILLION)
  • TABLE 58. NORTH AMERICA VIDEO LARYNGOSCOPE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 59. NORTH AMERICA VIDEO LARYNGOSCOPE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 60. NORTH AMERICA VIDEO LARYNGOSCOPE MARKET SIZE, BY PRIVATE HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 61. NORTH AMERICA VIDEO LARYNGOSCOPE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 62. LATIN AMERICA VIDEO LARYNGOSCOPE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. LATIN AMERICA VIDEO LARYNGOSCOPE MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 64. LATIN AMERICA VIDEO LARYNGOSCOPE MARKET SIZE, BY DISPOSABLE STATUS, 2018-2032 (USD MILLION)
  • TABLE 65. LATIN AMERICA VIDEO LARYNGOSCOPE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 66. LATIN AMERICA VIDEO LARYNGOSCOPE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 67. LATIN AMERICA VIDEO LARYNGOSCOPE MARKET SIZE, BY PRIVATE HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 68. LATIN AMERICA VIDEO LARYNGOSCOPE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 69. EUROPE, MIDDLE EAST & AFRICA VIDEO LARYNGOSCOPE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 70. EUROPE, MIDDLE EAST & AFRICA VIDEO LARYNGOSCOPE MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 71. EUROPE, MIDDLE EAST & AFRICA VIDEO LARYNGOSCOPE MARKET SIZE, BY DISPOSABLE STATUS, 2018-2032 (USD MILLION)
  • TABLE 72. EUROPE, MIDDLE EAST & AFRICA VIDEO LARYNGOSCOPE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 73. EUROPE, MIDDLE EAST & AFRICA VIDEO LARYNGOSCOPE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 74. EUROPE, MIDDLE EAST & AFRICA VIDEO LARYNGOSCOPE MARKET SIZE, BY PRIVATE HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 75. EUROPE, MIDDLE EAST & AFRICA VIDEO LARYNGOSCOPE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE VIDEO LARYNGOSCOPE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. EUROPE VIDEO LARYNGOSCOPE MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 78. EUROPE VIDEO LARYNGOSCOPE MARKET SIZE, BY DISPOSABLE STATUS, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE VIDEO LARYNGOSCOPE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 80. EUROPE VIDEO LARYNGOSCOPE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE VIDEO LARYNGOSCOPE MARKET SIZE, BY PRIVATE HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE VIDEO LARYNGOSCOPE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 83. MIDDLE EAST VIDEO LARYNGOSCOPE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. MIDDLE EAST VIDEO LARYNGOSCOPE MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 85. MIDDLE EAST VIDEO LARYNGOSCOPE MARKET SIZE, BY DISPOSABLE STATUS, 2018-2032 (USD MILLION)
  • TABLE 86. MIDDLE EAST VIDEO LARYNGOSCOPE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 87. MIDDLE EAST VIDEO LARYNGOSCOPE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 88. MIDDLE EAST VIDEO LARYNGOSCOPE MARKET SIZE, BY PRIVATE HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 89. MIDDLE EAST VIDEO LARYNGOSCOPE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 90. AFRICA VIDEO LARYNGOSCOPE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. AFRICA VIDEO LARYNGOSCOPE MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 92. AFRICA VIDEO LARYNGOSCOPE MARKET SIZE, BY DISPOSABLE STATUS, 2018-2032 (USD MILLION)
  • TABLE 93. AFRICA VIDEO LARYNGOSCOPE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 94. AFRICA VIDEO LARYNGOSCOPE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 95. AFRICA VIDEO LARYNGOSCOPE MARKET SIZE, BY PRIVATE HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 96. AFRICA VIDEO LARYNGOSCOPE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC VIDEO LARYNGOSCOPE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC VIDEO LARYNGOSCOPE MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC VIDEO LARYNGOSCOPE MARKET SIZE, BY DISPOSABLE STATUS, 2018-2032 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC VIDEO LARYNGOSCOPE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC VIDEO LARYNGOSCOPE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC VIDEO LARYNGOSCOPE MARKET SIZE, BY PRIVATE HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC VIDEO LARYNGOSCOPE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL VIDEO LARYNGOSCOPE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. ASEAN VIDEO LARYNGOSCOPE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. ASEAN VIDEO LARYNGOSCOPE MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 107. ASEAN VIDEO LARYNGOSCOPE MARKET SIZE, BY DISPOSABLE STATUS, 2018-2032 (USD MILLION)
  • TABLE 108. ASEAN VIDEO LARYNGOSCOPE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 109. ASEAN VIDEO LARYNGOSCOPE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 110. ASEAN VIDEO LARYNGOSCOPE MARKET SIZE, BY PRIVATE HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 111. ASEAN VIDEO LARYNGOSCOPE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 112. GCC VIDEO LARYNGOSCOPE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GCC VIDEO LARYNGOSCOPE MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 114. GCC VIDEO LARYNGOSCOPE MARKET SIZE, BY DISPOSABLE STATUS, 2018-2032 (USD MILLION)
  • TABLE 115. GCC VIDEO LARYNGOSCOPE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. GCC VIDEO LARYNGOSCOPE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 117. GCC VIDEO LARYNGOSCOPE MARKET SIZE, BY PRIVATE HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 118. GCC VIDEO LARYNGOSCOPE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPEAN UNION VIDEO LARYNGOSCOPE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPEAN UNION VIDEO LARYNGOSCOPE MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPEAN UNION VIDEO LARYNGOSCOPE MARKET SIZE, BY DISPOSABLE STATUS, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPEAN UNION VIDEO LARYNGOSCOPE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPEAN UNION VIDEO LARYNGOSCOPE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPEAN UNION VIDEO LARYNGOSCOPE MARKET SIZE, BY PRIVATE HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPEAN UNION VIDEO LARYNGOSCOPE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 126. BRICS VIDEO LARYNGOSCOPE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. BRICS VIDEO LARYNGOSCOPE MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 128. BRICS VIDEO LARYNGOSCOPE MARKET SIZE, BY DISPOSABLE STATUS, 2018-2032 (USD MILLION)
  • TABLE 129. BRICS VIDEO LARYNGOSCOPE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. BRICS VIDEO LARYNGOSCOPE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 131. BRICS VIDEO LARYNGOSCOPE MARKET SIZE, BY PRIVATE HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 132. BRICS VIDEO LARYNGOSCOPE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. G7 VIDEO LARYNGOSCOPE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. G7 VIDEO LARYNGOSCOPE MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 135. G7 VIDEO LARYNGOSCOPE MARKET SIZE, BY DISPOSABLE STATUS, 2018-2032 (USD MILLION)
  • TABLE 136. G7 VIDEO LARYNGOSCOPE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 137. G7 VIDEO LARYNGOSCOPE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 138. G7 VIDEO LARYNGOSCOPE MARKET SIZE, BY PRIVATE HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 139. G7 VIDEO LARYNGOSCOPE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 140. NATO VIDEO LARYNGOSCOPE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. NATO VIDEO LARYNGOSCOPE MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 142. NATO VIDEO LARYNGOSCOPE MARKET SIZE, BY DISPOSABLE STATUS, 2018-2032 (USD MILLION)
  • TABLE 143. NATO VIDEO LARYNGOSCOPE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 144. NATO VIDEO LARYNGOSCOPE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 145. NATO VIDEO LARYNGOSCOPE MARKET SIZE, BY PRIVATE HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 146. NATO VIDEO LARYNGOSCOPE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL VIDEO LARYNGOSCOPE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. UNITED STATES VIDEO LARYNGOSCOPE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 149. UNITED STATES VIDEO LARYNGOSCOPE MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 150. UNITED STATES VIDEO LARYNGOSCOPE MARKET SIZE, BY DISPOSABLE STATUS, 2018-2032 (USD MILLION)
  • TABLE 151. UNITED STATES VIDEO LARYNGOSCOPE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. UNITED STATES VIDEO LARYNGOSCOPE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 153. UNITED STATES VIDEO LARYNGOSCOPE MARKET SIZE, BY PRIVATE HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 154. UNITED STATES VIDEO LARYNGOSCOPE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 155. CHINA VIDEO LARYNGOSCOPE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 156. CHINA VIDEO LARYNGOSCOPE MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 157. CHINA VIDEO LARYNGOSCOPE MARKET SIZE, BY DISPOSABLE STATUS, 2018-2032 (USD MILLION)
  • TABLE 158. CHINA VIDEO LARYNGOSCOPE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 159. CHINA VIDEO LARYNGOSCOPE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 160. CHINA VIDEO LARYNGOSCOPE MARKET SIZE, BY PRIVATE HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 161. CHINA VIDEO LARYNGOSCOPE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)